title: Bisphosphonates: forever or 5 years and stop?
authors.affiliation: Associate Professor in the Department of Family Medicine.
authors.forename: Michael R
authors.initials: MR
authors.lastname: Kolber
authors.affiliation: Associate Professor in the Faculty of Pharmacy and Pharmaceutical Sciences.
authors.forename: Cheryl A
authors.initials: CA
authors.lastname: Sadowski
authors.affiliation: Associate Professor in the Department of Family Medicine, all at the University of Alberta in Edmonton.
authors.forename: Christina
authors.initials: C
authors.lastname: Korownyk
mesh_terms: D050071:Bone Density Conservation Agents / Q000008:administration & dosage*; D004164:Diphosphonates / Q000008:administration & dosage*; D004334:Drug Administration Schedule; D005260:Female; D050723:Fractures, Bone / Q000517:prevention & control; D006801:Humans; D008875:Middle Aged; D010024:Osteoporosis / Q000188:drug therapy*; D012306:Risk; D013997:Time Factors; D028761:Withholding Treatment
chemical_list: D050071:Bone Density Conservation Agents; D004164:Diphosphonates